News and Trends 30 Nov 2016
Drugging the Undruggable: New Acquisition to Boost GPCR Drugs
…up to 30% of approved drugs and can hold the key to treating many diseases, ranging from Alzheimer’s to cancer. However, their conformational flexibility in solution is a huge challenge…